Clinical trial
Prospective, Non-Randomized, Open-Label, Single Center Study to Evaluate the Performance of the Travoprost Intraocular Implant
NCT06582732 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-Randomized, Open-Label, Single Center Study to Evaluate the Performance of the Travoprost Intraocular Implant
- Lead sponsor
- Glaukos Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 10, 2021
- Completion date
- November 2, 2023
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.